Journals / JAREM / 2012 / Cilt: 2 - Sayı: 3

Erythrodermia development after ıbuprofen use in an infant and review of literature

İbuprofen kullanımına bağlı süt çocuğunda görülen eritrodermi olgusu ve literatürün gözden geçirilmesi

Journal
JAREM
Pages
127–130
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With this report, we wish to increase awareness of clinicians and family members regarding ibuprofen-associated erythrodermia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Erythrodermia, also known as exfoliative dermatitis, is an inflammatory and life-threatening disorder presenting with erythema and squamous lesions covering more than 90% of the body.
📊
Key Findings & Data:A 10-month-old girl had been given ibuprofen because of high fever and agitation.
💡
Conclusion & Impact:With this report, we wish to increase awareness of clinicians and family members regarding ibuprofen-associated erythrodermia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Erythrodermia, also known as exfoliative dermatitis, is an inflammatory and life-threatening disorder presenting with erythema and squamous lesions covering more than 90% of the body. When a large case series is evaluated for etiological reasons, non-steroid anti-inflammatory drugs, specifically ibuprofen, should be considered be one of the rarest predisposing factors. A 10-month-old girl had been given ibuprofen because of high fever and agitation. Hours after ibuprofen use, she had developed generalized erythema and presented to our hospital. After antihistaminic and steroid injec- tions in emergency, the rash did not vanish and she was admitted to our clinic. Her complete blood count, C-reactive protein and routine biochem- istry values were found to be normal. In addition to electrolyte therapy, dexamethasone was given for the rash. On consultation with dermatology, erythrodermia, probably due to ibuprofen, was suspected and topical eau de goulard, hydrocortisone cream and diphenhydramine were added to the therapy. She was monitorized for vital signs and kept warm. At the fifth day of admission; the rash resolved and she was discharged. As a result; although erythrodermia has been frequently reported to be associated with various underlying diseases such as skin disorders, medications, and malignancies; in our case it seemed to be caused by ibuprofen. Additionally, the patients who have sthis kind of skin lesion should be questioned for any medication being used. It should be kept in mind that ibuprofen, as a commonly used antipyretic medication, may rarely cause erythrodermia, which may sometimes be a life-threatening complication. With this report, we wish to increase awareness of clinicians and family members regarding ibuprofen-associated erythrodermia.

Özet

Eksfoliyatif dermatit olarak da bilinen eritrodermi, eritem ve vücudun %90’ından fazlasının skuamöz lezyonlarla kaplandığı enflamatuar ve yaşamı teh- dit eden bir hastalıktır. Geniş vaka serileri etyolojik nedenler göz önüne alınarak incelendiğinde, steroid olmayan anti-enflamatuar ilaçların, özellikle ibuprofen’in, altta yatan nadir nedenlerden biri olduğu dikkati çekmektedir. On aylık bir kız çocuğuna yüksek ateş ve ajitasyondan dolayı ibuprofen verilmişti. İbuprofen verildikten saatler sonra hasta yaygın eritem geliştirerek hastanemize başvurmuştu. Acilde antihistaminik ve steroid kullanılmasına rağmen, döküntüsü kaybolmaması üzerine kliniğimize yatırılmıştı. Hastamızın tam kan sayımı, CRP ve biokimyasal değerleri normaldi. Elektrolit tedavi- sine ilaveten, döküntü için deksametazon da verildi. Dermatolojiyle konsülte edildiğinde, ibuprofen’e bağlı eritrodermiden şüphelenilerek topikal eau de goulard, hidrokortizon krem ve difenhidramin tedavisine eklendi. Hasta vital bulgularının gözlemi için monitorize edildi ve sıcak tutuldu. Yatışının 5. gününde döküntü geriledi ve hasta taburcu edildi. Sonuçta eritrodermi altta yatan cilt hastalığı, ilaçlar, tümörler gibi değişik hastalıklarla ilişkili bulun- masına rağmen; hastamızda ibuprofen’e bağlandı. Bundan dolayı, bu tür cilt lezyonları olan hastalarda ilaç kullanımı sorgulanmalıdır. İbuprofen gibi sık kullanılan bir antipiretiğin nadiren eritrodemi gibi hayatı tehdit edebilen komplikasyona yol açabileceği akılda tutulmalıdır. Bu sunumla, özellikle klinisyen ve aile üyelerinde ibuprofen’le ilişkili eritroderminin farkındalığını artırmak istedik.

🔖

Cite This Article

ÖZDEMİR, Ö., UZAN, Z. T., KIRAL, A., ÖZKAN, B. (2012). Erythrodermia development after ıbuprofen use in an infant and review of literature. JAREM, Cilt: 2 - Sayı: 3, 127–130. https://ajindex.com/articles/215518

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Jih MH, Kimyai Asadi A, Freedberg IM. Exfoliative dermatitis. In: Fre- edberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Kastz SI, editors. Fitzpatrick’s dermatology in general medicine, 6th ed. New York: McGraw-Hill; 2003; 436-9
  2. Nicolis GD, Helwig EB. Exfoliative dermatitis. A clinic-pathologic study of 135 cases. Arch Dermatol 1973; 108: 788-97. [CrossRef] 3. Sarkar R, Sharma RC, Koranne RV, Sardana K. Erythroderma in child- ren: A clinico-etiological study. J Dermatol 1999; 26: 507-11
  3. Sarkar R, Garg VK. Erythroderma in children. Indian J Dermatol Ve- nereol Leprol 2010; 76: 341-7. [CrossRef] 5. Sarkar R, Basu S, Sharma RC. Neonatal and infantile erythroderma. Arch Dermatol 2001; 137: 822-3
  4. Edwards RI, Aronson JK. Adverse drug reactions: definitions, diag- nosis, and management. The Lancet 2000; 356: 1255-9. [CrossRef] 7. Roujeau JC. Clinical aspects of skin reactions to NSAIDs. Scand J Rheumatol Suppl 1987; 65: 131-4. [CrossRef] 8. Ozdemir O. Development of antiepileptic hypersensitivity syndrome after phenytoin treatment. Turk J Pediatr 2010; 52: 111-2
  5. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139: 683-93
  6. Pruszkowski A, Bodemer C, Fraitag S, Teillac-Hamel D, Amoric JC, de Prost Y. Neonatal and infantile erythroderma: A retrospective study of 51 patients. Arch Dermatol 2000; 136: 875-80. [CrossRef] 11. Raksha MP, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol 2008; 74: 80. [CrossRef] 12. Malhotra S, Chopra SC, Dogra A, Gupta C. Cutaneous adverse drug reactions- one year pharmacovigilance study in a tertiary care hospi- tal. Indian J Pharmacol 2004; 36: S41-2
  7. Jhaj R, Uppal R, Malhotra S, Bhargava VK. Cutaneous adverse re- actions in in-patients in a tertiary care hospital. Indian J Dermatol Venereol Leprol 1999; 65: 14-7
  8. Heinzerling LM, Tomsitz D, Anliker MD. Is drug allergy less prevalent than previously assumed? A 5-year analysis. Br J Dermatol 2012; 166: 107-14. [CrossRef] 15. Cook DJ, Achong MR, Murphy FR. Three cases of diflunisal hyper- sensitivity. CMAJ 1988; 138: 1029-30
  9. Bernedo N, Audicana MT, Uriel O, Velasco M, Gastaminza G, Fernández E, et al. Metamizol as a cause of postoperative erythro- derma. Contact Dermatitis 2004; 50: 317-8. [CrossRef] 17. Iemoli E, Piconi S, Ardizzone S, Bianchi Porro G, Raimond F. Erythro- derma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid. Inflamm Bowel Dis 2006